ATRITECH
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term anticoagulation therapy for patients with non-valvular atrial fibrillation at risk of stroke. The first implants of the WATCHMAN® Left Atrial Appendage Closure Technology were performed in Germany in August of 2002 and in the United States in October of 2003. Since then the company has conducted a large randomized clinical... trial comparing the WATCHMAN® Left Atrial Appendage Closure Technology to long term Warfarin therapy in patients with non-valvular atrial fibrillation at risk of stroke. The WATCHMAN® Device is CE Marked and available in many markets outside the United States. The WATCHMAN® Device is currently available For Investigational Use Only in the United States.
ATRITECH
Social Links:
Industry:
Clinical Trials Health Care Medical Device Therapeutics
Founded:
2000-01-01
Address:
Plymouth, Minnesota, United States
Country:
United States
Website Url:
http://www.atritech.net
Total Employee:
10001+
Status:
Active
Contact:
763.258.0250
Email Addresses:
[email protected]
Total Funding:
83.6 M USD
Technology used in webpage:
Domain Not Resolving Japanese Server Location
Similar Organizations
AUM LifeTech
AUM LifeTech is a Philadelphia based biotechnology company with a revolutionary nucleic acids platform.
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
RightAir
RightAir is developing noninvasive ventilators for COPD patients.
Investors List
Split Rock Partners
Split Rock Partners investment in Venture Round - Atritech
Vector Media Group
Vector Media Group investment in Venture Round - Atritech
Thomas, McNerney & Partners
Thomas, McNerney & Partners investment in Venture Round - Atritech
Tullis Health Investors
Tullis Health Investors investment in Venture Round - Atritech
Prism Venture Management
Prism Venture Management investment in Venture Round - Atritech
SightLine Partners
SightLine Partners investment in Series D - Atritech
Tullis Health Investors
Tullis Health Investors investment in Series D - Atritech
Affinity Capital Management
Affinity Capital Management investment in Series D - Atritech
Split Rock Partners
Split Rock Partners investment in Series D - Atritech
Thoma Bravo
Thoma Bravo investment in Series D - Atritech
Official Site Inspections
http://www.atritech.net
- Host name: ik1-447-55838.vs.sakura.ne.jp
- IP address: 133.125.59.92
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Atritech"
Atritech - Crunchbase Company Profile & Funding
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused on replacing long term …See details»
Atritech - Overview, News & Similar companies | ZoomInfo.com
Who is Atritech. Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technology focused o n replacing long …See details»
Atritech Company Profile 2024: Valuation, Investors ... - PitchBook
Affinity Capital Management, BioStar Capital, Cressey & Company, Edwards Lifesciences, and Prism Venture Management are 5 of 11 investors who have invested in Atritech. When was …See details»
Boston Scientific to Acquire Atritech - Jan 19, 2011
About Atritech. Atritech, Inc., founded in 2000, is dedicated to providing new therapies to treat patients suffering from atrial fibrillation who are at increased risk for stroke by offering …See details»
Atritech - Ownership and Business Overview - Mergr
Mar 3, 2011 www.atritech.net. Profile Investors (3) Analytics Atritech, Inc. is a clinical stage medical device company and developed the Watchman (a device to treat atrial fibrillation). …See details»
Boston Scientific to Acquire Atritech - PR Newswire
Jan 19, 2011 About Atritech. Atritech, Inc., founded in 2000, is dedicated to providing new therapies to treat patients suffering from atrial fibrillation who are at increased risk for stroke by …See details»
Boston Scientific to Acquire Atritech - TCTMD.com
Jan 19, 2011 Atritech will significantly strengthen our product offerings for patients with atrial fibrillation." "Both Atritech and Boston Scientific believe that the WATCHMAN device offers the …See details»
Boston Scientific Strengthens Structural Heart Product Portfolio By ...
Mar 3, 2011 About Atritech. Atritech, Inc., founded in 2000, is dedicated to providing new therapies to treat patients suffering from atrial fibrillation who are at increased risk for stroke by …See details»
Atritech - Contacts, Employees, Board Members, Advisors & Alumni
Atritech is a private company located in Minneapolis, Minnesota. The company was founded in 2000 and has developed proprietary technologySee details»
Atritech Has Been Acquired by Boston Scientific
Mar 3, 2011 Boston Scientific (NYSE: BSX), a Marlborough, MA based worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties, …See details»
Boston Scientific to Acquire Atritech - Today's Medical …
Jan 21, 2011 About Atritech Atritech, Inc., founded in 2000, is dedicated to providing new therapies to treat patients suffering from atrial fibrillation who are at increased risk for stroke by …See details»
Atritech - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised ... Unlock for free . Mar 26, 2009: Venture Round …See details»
Boston Scientific Strengthens Structural Heart Product Portfolio By ...
Mar 3, 2011 Atritech, Inc., founded in 2000, is dedicated to providing new therapies to treat patients suffering from atrial fibrillation who are at increased risk for stroke by offering …See details»
Boston Scientific Strengthens Structural Heart Product Portfolio By ...
Mar 3, 2011 "Left atrial appendage closure represents a significant growth opportunity for Boston Scientific, and Atritech's WATCHMAN® device is the first such product for atrial fibrillation …See details»
Atritech Management Team - CB Insights
Explore {Atritech's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Technology Vendors ... atritech.net. …See details»
Atritech - Crunchbase Company Profile & Funding
Organization. Atritech . Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. About. ... Find More Contacts for Atritech. Protected Content. CEO. Non …See details»
Atritech, Inc. Announces FDA Regulatory Update; Confirmatory …
Mar 22, 2010 Atritech, Inc. Announces FDA Regulatory Update; Confirmatory Study Required for Final FDA Approval 3/19/2010 MINNEAPOLIS, March 18 /PRNewswire/ -- Atritech, Inc., an …See details»
Atritech, Inc. Announces Completion of a $22 Million Equity
MINNEAPOLIS, Sept. 5 /PRNewswire/ -- Atritech, Inc., a clinical stage medical device company, announced today that it has completed a $22 million round of financing. SightLine Healthcare …See details»
Atritech - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 3, 2024 Atritech uses 4 technology products and services including HTML5, F5 NGINX, and Google Fonts, according to G2 Stack. Atritech is actively using 27 technologies for its website, …See details»
The WATCHMAN Left Atrial Appendage Closure Device for Atrial ...
The authors thank Ms. Maggie Wallner (Atritech Inc./ Boston Scientific) for critical review of the article. The authors want to thank Mr. Mahesh Deshpanade (Boston Scientific) for his …See details»